About Careers MedBlog Contact us

Plea in Delhi HC for Fare Concession to Cancer Patients in Rajdhani Express

by Bidita Debnath on January 16, 2017 at 10:00 PM
Font : A-A+

 Plea in Delhi HC for Fare Concession to Cancer Patients in Rajdhani Express

A Public Interest Litigation (PIL) was filed before the Delhi High Court seeking direction for the Railway Ministry to provide fare concession for cancer patients in Rajdhani Express to reduce their financial burden and travel time during such a tough period.

The PIL filed by an NGO - Fariyaad Foundation - said major hospitals specialised in treatment of cancer are situated in metropolitan cities and it would be beneficial for patients if they were provided fare concession in Rajdhani Express starts as it covers most of the big cities in lesser time.


"Oncologists in the country are irregularly distributed and are heavily concentrated in the urban areas of the country. As Rajdhani Express is one of the preferred means within the reach of the masses for long, safe, speedy and comfortable travel, it is indispensable that cancer patients and their assistants are provided concessions for the same," the plea said.

The plea mentioned the data of the Indian Council of Medical Research (ICMR) as per which estimated number of people living with cancer in India is around 2.5 million, and every year, about 7 lakh new cancer cases are registered while about 5,56,400 people die suffering from the same.

"Official data show there are only about 1,000 trained oncologists in the country and the ratio of oncologists to cancer patients is about 1:2,000. The patient load is more in smaller towns, there is a dearth of oncologists and infrastructure in these regions. India has 27 dedicated cancer hospitals and an additional 300 general or multi-specialty ones providing care to cancer patients," said the petition.

The NGO said it had filed an RTI application in September last year seeking information regarding sections of persons getting concessions in Rajdhani Express, to which ministry provided the list of beneficiaries, and also stated that cancer patients and attendant are not being provided concessions.

The plea also sought direction for the ministry to provide emergency quotas for reservation to the post-chemotherapy patients.

The plea likely to come up for hearing on January 18.

Source: IANS


Recommended Reading

Latest Cancer News

 Myelofibrosis: New Drugs to Revolutionize Treatment
The approvals of pipeline drugs such as momelotinib and Vonjo for myelofibrosis (a rare type of blood cancer) over some time will handle the critical unmet needs.
 Blood Vessels Can Kill Cancer Cells and Stop Breast Cancer Spread
New study highlights the dual role that blood vessels can play in cancer immunotherapy and eliciting anti-tumor immune responses or even preventing breast cancer spread.
 Weed Killer Agent Orange May Increase the Risk of Blood Cancer Among Veterans
New study evaluated the association between exposure to the chemical agent orange and the development of blood cancer with increased bleeding and blood clot formation.
Two Years: Optimal Duration of Immunotherapy in Advanced Lung Cancer
Study suggests two-year immunotherapy treatment for advanced lung cancer may be reasonable
Hope for Lethal Brain Tumors: Targeted Therapy Delays Glioma Progression
A ray of hope for glioma patients as targeted therapy boosts treatment duration.
View All
This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close

Plea in Delhi HC for Fare Concession to Cancer Patients in Rajdhani Express Personalised Printable Document (PDF)

Please complete this form and we'll send you a personalised information that is requested

You may use this for your own reference or forward it to your friends.

Please use the information prudently. If you are not a medical doctor please remember to consult your healthcare provider as this information is not a substitute for professional advice.

Name *

Email Address *

Country *

Areas of Interests